Adjuvant Cetuximab and Chemoradiation in Head and Neck Cancer
Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
This multicenter, open-label, uncontrolled phase II trial evaluates safety and efficacy of
post-operative chemoradiation in combination with cetuximab in squamous cell carcinoma of the
head and neck.